I'd be interested to hear of examples you have of takeovers...

I'd be interested to hear of examples you have of takeovers taking place at 5 x market cap.

I really don't think the market is being held back by any concerns about manufacturing.

It seems from yesterday's presentation that MT has made his mind up about chasing a takeover rather than a partnership or licensing deal. That seems like a shame to me.

Looking at other ASX listed pharma companies similar to us, news of licensing deals can be a major catalyst to share price appreciation. And there is no reason why we can't start negotiating some of those deals now. DXB offers a great example of how this can be achieved.

If we negotiated a licensing deal this year with an upfront cash payment, we could potentially use that cash to fund a Phase II trial in a second indication in 2025.